Winston Medical Supply Co., Ltd. (TPEX:6817)

Winston Medical Supply Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	724.35	695.08	709.07	606.52	536.53	505.12
Revenue Growth (YoY)	3.60%	-1.97%	16.91%	13.05%	6.22%	38.43%
Cost of Revenue	401.75	379.24	361.48	342.07	299.13	301.3
Gross Profit	322.6	315.84	347.6	264.45	237.39	203.82
Selling, General & Admin	150.08	147.16	142.87	122.89	113.21	113.84
Research & Development	9.74	9.43	8.64	7	7.72	6.3
Operating Expenses	159.83	156.59	151.5	128.59	122.11	120.1
Operating Income	162.78	159.26	196.1	135.86	115.29	83.72
Interest Expense	-1.14	-1.17	-1.53	-1.06	-1.84	-3.11
Interest & Investment Income	2.82	2.85	2.01	0.4	0.17	0.08
Currency Exchange Gain (Loss)	-0.88	0.39	-0.19	0.08	-0.2	0.93
Other Non Operating Income (Expenses)	3.82	3.96	3.46	6.11	3.42	3.93
EBT Excluding Unusual Items	167.39	165.29	199.85	141.4	116.84	85.54
Gain (Loss) on Sale of Assets	-0.74	-1.11	-1.03	-	-0.25	0.21
Pretax Income	166.66	164.18	198.82	141.4	116.59	85.75
Income Tax Expense	32.42	32.59	40.06	30.14	24.46	-13.93
Earnings From Continuing Operations	134.23	131.59	158.76	111.26	92.13	99.69
Net Income to Company	134.23	131.59	158.76	111.26	92.13	99.69
Net Income	134.23	131.59	158.76	111.26	92.13	99.69
Net Income to Common	134.23	131.59	158.76	111.26	92.13	99.69
Net Income Growth	-10.41%	-17.11%	42.69%	20.77%	-7.58%	-
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
Shares Change (YoY)	-0.01%	-0.04%	-	0.27%	3.93%	1.44%
EPS (Basic)	7.29	7.15	8.62	6.04	5.04	5.68
EPS (Diluted)	7.26	7.12	8.58	6.01	4.99	5.62
EPS Growth	-10.38%	-17.02%	42.76%	20.44%	-11.21%	-
Free Cash Flow	132.33	130.24	196.41	118.49	141.4	108.84
Free Cash Flow Per Share	7.16	7.04	10.62	6.41	7.67	6.13
Dividend Per Share	7.000	7.000	6.600	5.000	4.000	3.000
Dividend Growth	6.06%	6.06%	32.00%	25.00%	33.33%	-
Gross Margin	44.54%	45.44%	49.02%	43.60%	44.25%	40.35%
Operating Margin	22.47%	22.91%	27.66%	22.40%	21.49%	16.57%
Profit Margin	18.53%	18.93%	22.39%	18.34%	17.17%	19.73%
Free Cash Flow Margin	18.27%	18.74%	27.70%	19.54%	26.36%	21.55%
EBITDA	187.31	185.07	221.25	171.37	149.31	118.2
EBITDA Margin	25.86%	26.63%	31.20%	28.26%	27.83%	23.40%
D&A For EBITDA	24.54	25.82	25.15	35.51	34.03	34.48
EBIT	162.78	159.26	196.1	135.86	115.29	83.72
EBIT Margin	22.47%	22.91%	27.66%	22.40%	21.49%	16.57%
Effective Tax Rate	19.46%	19.85%	20.15%	21.31%	20.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.